360 filings
6-K
TLSA
Tiziana Life Sciences Ltd
18 Apr 24
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
11 Apr 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
5 Mar 24
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
8 Jan 24
Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
5 Jan 24
Report of Foreign Private Issuer
9:30am
6-K
TLSA
Tiziana Life Sciences Ltd
5 Jan 24
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
29 Dec 23
Updated Interim Results for the Six Months Ended 30 June 2023
4:30pm
6-K
TLSA
Tiziana Life Sciences Ltd
19 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
4 Dec 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
1 Dec 23
To Be Held As a “Remote Meeting” Only
9:00am
6-K
TLSA
Tiziana Life Sciences Ltd
30 Nov 23
Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis
7:08am
6-K
TLSA
Tiziana Life Sciences Ltd
1 Nov 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
18 Oct 23
Tiziana Life Sciences Announces Allowance By FDA For At-Home Dosing Of Intranasal Foralumab For Multiple Sclerosis Treatment
7:12am
6-K
TLSA
Tiziana Life Sciences Ltd
16 Oct 23
Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple Sclerosis Patients Treated with Intranasal Foralumab
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
13 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
11 Oct 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
26 Sep 23
Report of Foreign Private Issuer
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
8 Sep 23
Tiziana Life Sciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
7:00am
6-K
TLSA
Tiziana Life Sciences Ltd
6 Sep 23
Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance
7:00am
424B5
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Prospectus supplement for primary offering
5:16pm